Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response

Sepsis remains a leading cause of death for humans and currently has no pathogenesis-specific therapy. Hampered progress is partly due to a lack of insight into deep mechanistic processes. In the past decade, deciphering the functions of small noncoding miRNAs in sepsis pathogenesis became a dynamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dragomir, Mihnea P., Fuentes-Mattei, Enrique, Winkle, Melanie, Okubo, Keishi, Bayraktar, Recep, Knutsen, Erik, Qdaisat, Aiham, Chen, Meng, Li, Yongfeng, Shimizu, Masayoshi, Pang, Lan, Liu, Kevin, Liu, Xiuping, Anfossi, Simone, Zhang, Huanyu, Koch, Ines, Tran, Anh M., Mohapatra, Swati, Ton, Anh, Kaplan, Mecit, Anderson, Matthew W., Rothfuss, Spencer J., Silasi, Robert, Keshari, Ravi S., Ferracin, Manuela, Ivan, Cristina, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Georgescu, Constantin, Banerjee, Pinaki P., Basar, Rafet, Li, Ziyi, Horst, David, Vasilescu, Catalin, Bertilaccio, Maria Teresa S., Rezvani, Katayoun, Lupu, Florea, Yeung, Sai-Ching, Calin, George A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348769/
https://www.ncbi.nlm.nih.gov/pubmed/37261908
http://dx.doi.org/10.1172/JCI158348

Ejemplares similares

Ejemplares similares